Indomethacin Lowers Urinary Calcium Excretion in Normal Volunteers and Normocalciuric Stone-Formers
Indomethacin, a non-steroidal anti-inflammatory agent, has been shown to alter calcium metabolism in patients with metastatic carcinoma. This study was designed to determine the effects of indomethacin on urinary calcium excretion in 20 normal volunteers and 8 patients with urolithiasis.
KeywordsNormal Volunteer Urinary Calcium Metastatic Carcinoma Sodium Diet Urinary Calcium Excretion
Unable to display preview. Download preview PDF.